In the present study, we found that miR‐222 promoted the proliferation of bladder cancer cells and attenuated CDDP‐induced cell death by regulating the PPP2R2A/Akt/mTOR axis, which indicated that miR‐222 might be a novel therapeutic target for bladder cancer. This evidence concerns the gene AKT1 and urinary bladder cancer.